194 related articles for article (PubMed ID: 38275073)
41. Piperazine-2-carboxylic acid derivatives as MTDLs anti-Alzheimer agents: Anticholinesterase activity, mechanistic aspect, and molecular modeling studies.
Soliman AM; Abd El-Wahab HAA; Akincioglu H; Gülçin İ; Omar FA
Bioorg Chem; 2024 Jan; 142():106916. PubMed ID: 37913584
[TBL] [Abstract][Full Text] [Related]
42. Design, synthesis and evaluation of 4-dimethylamine flavonoid derivatives as potential multifunctional anti-Alzheimer agents.
Luo W; Wang T; Hong C; Yang YC; Chen Y; Cen J; Xie SQ; Wang CJ
Eur J Med Chem; 2016 Oct; 122():17-26. PubMed ID: 27343850
[TBL] [Abstract][Full Text] [Related]
43. New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and β-Amyloid aggregation for treatment of Alzheimer's disease.
El-Sayed NF; El-Hussieny M; Ewies EF; Fouad MA; Boulos LS
Bioorg Chem; 2020 Jan; 95():103499. PubMed ID: 31838287
[TBL] [Abstract][Full Text] [Related]
44. Synthesis, biological evaluation of 9-N-substituted berberine derivatives as multi-functional agents of antioxidant, inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation.
Shan WJ; Huang L; Zhou Q; Meng FC; Li XS
Eur J Med Chem; 2011 Dec; 46(12):5885-93. PubMed ID: 22019228
[TBL] [Abstract][Full Text] [Related]
45. Interest of novel N-alkylpyridinium-indolizine hybrids in the field of Alzheimer's disease: Synthesis, characterization and evaluation of antioxidant activity, cholinesterase inhibition, and amyloid fibrillation interference.
Baussanne I; Firstova O; Dediu AB; Larosa C; Furdui B; Ghinea IO; Thomas A; Chierici S; Dinica R; Demeunynck M
Bioorg Chem; 2021 Nov; 116():105390. PubMed ID: 34670332
[TBL] [Abstract][Full Text] [Related]
46. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
[TBL] [Abstract][Full Text] [Related]
47. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
He Y; Yao PF; Chen SB; Huang ZH; Huang SL; Tan JH; Li D; Gu LQ; Huang ZS
Eur J Med Chem; 2013 May; 63():299-312. PubMed ID: 23501115
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and Evaluation of Novel Ligustrazine Derivatives as Multi-Targeted Inhibitors for the Treatment of Alzheimer's Disease.
Wu W; Liang X; Xie G; Chen L; Liu W; Luo G; Zhang P; Yu L; Zheng X; Ji H; Zhang C; Yi W
Molecules; 2018 Oct; 23(10):. PubMed ID: 30301153
[TBL] [Abstract][Full Text] [Related]
50. Design, synthesis,
Mo J; Chen T; Yang H; Guo Y; Li Q; Qiao Y; Lin H; Feng F; Liu W; Chen Y; Liu Z; Sun H
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):330-343. PubMed ID: 31856607
[TBL] [Abstract][Full Text] [Related]
51. Design, synthesis and biological evaluation of new benzoxazolone/benzothiazolone derivatives as multi-target agents against Alzheimer's disease.
Erdogan M; Kilic B; Sagkan RI; Aksakal F; Ercetin T; Gulcan HO; Dogruer DS
Eur J Med Chem; 2021 Feb; 212():113124. PubMed ID: 33395623
[TBL] [Abstract][Full Text] [Related]
52. New benzyl pyridinium derivatives bearing 2,4-dioxochroman moiety as potent agents for treatment of Alzheimer's disease: Design, synthesis, biological evaluation, and docking study.
Mollazadeh M; Mohammadi-Khanaposhtani M; Zonouzi A; Nadri H; Najafi Z; Larijani B; Mahdavi M
Bioorg Chem; 2019 Jun; 87():506-515. PubMed ID: 30928873
[TBL] [Abstract][Full Text] [Related]
53. Identification of sulfonamide based butyrylcholinesterase inhibitors through scaffold hopping approach.
Ganeshpurkar A; Singh R; Kumar D; Gore P; Shivhare S; Sardana D; Rayala S; Kumar A; Singh SK
Int J Biol Macromol; 2022 Apr; 203():195-211. PubMed ID: 35090939
[TBL] [Abstract][Full Text] [Related]
54. Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents.
Jameel E; Meena P; Maqbool M; Kumar J; Ahmed W; Mumtazuddin S; Tiwari M; Hoda N; Jayaram B
Eur J Med Chem; 2017 Aug; 136():36-51. PubMed ID: 28478343
[TBL] [Abstract][Full Text] [Related]
55. Design, synthesis, and activity evaluation of novel multitargeted l-tryptophan derivatives with powerful antioxidant activity against Alzheimer's disease.
Zeng X; Cheng S; Li H; Yu H; Cui Y; Fang Y; Yang S; Feng Y
Arch Pharm (Weinheim); 2024 May; 357(5):e2300603. PubMed ID: 38290060
[TBL] [Abstract][Full Text] [Related]
56. Design, synthesis, and multitargeted profiling of N-benzylpyrrolidine derivatives for the treatment of Alzheimer's disease.
Choubey PK; Tripathi A; Sharma P; Shrivastava SK
Bioorg Med Chem; 2020 Nov; 28(22):115721. PubMed ID: 33007563
[TBL] [Abstract][Full Text] [Related]
57. Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation.
Xu A; He F; Zhang X; Li X; Ran Y; Wei C; James Chou C; Zhang R; Wu J
Bioorg Chem; 2020 May; 98():103721. PubMed ID: 32193030
[TBL] [Abstract][Full Text] [Related]
58. Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents.
Luo W; Su YB; Hong C; Tian RG; Su LP; Wang YQ; Li Y; Yue JJ; Wang CJ
Bioorg Med Chem; 2013 Dec; 21(23):7275-82. PubMed ID: 24148835
[TBL] [Abstract][Full Text] [Related]
59. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
Wang DM; Feng B; Fu H; Liu AL; Wang L; Du GH; Wu S
Molecules; 2017 Jan; 22(1):. PubMed ID: 28117700
[TBL] [Abstract][Full Text] [Related]
60. Synthesis, molecular docking, and biological activity of 2-vinyl chromones: Toward selective butyrylcholinesterase inhibitors for potential Alzheimer's disease therapeutics.
Makhaeva GF; Boltneva NP; Lushchekina SV; Rudakova EV; Serebryakova OG; Kulikova LN; Beloglazkin AA; Borisov RS; Richardson RJ
Bioorg Med Chem; 2018 Sep; 26(16):4716-4725. PubMed ID: 30104121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
